Stocks
Agios Pharmaceuticals (AGIO) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -5.77 | -7.83 | -2.07 | -1.00 | -1.39 | -1.68 | ||
| Changes by years, y/y, % | +14% | +36% | -74% | -52% | +39% | -22.9% | |||
Agios Pharmaceuticals. EV/EBITDA
Agios Pharmaceuticals. EV/EBITDA, changes, %
Agios Pharmaceuticals (AGIO) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -0.66 | -1.40 | -1.14 | -1.38 | -2.87 | -1.68 | |
| Changes by years, y/y, % | -68% | +9% | -52% | -15% | +331% | |||
| Changes by quarters, q/q, % | -59% | +110% | -18% | +21% | +107% | |||
